BUDGET TRACKING SERVICES
BioBoston CRO provides clinical trial budget management support for sponsors that need a controlled view of baseline commitments, forecasts, actuals, accrual inputs, vendor proposals, pass-through costs, change orders, cost-to-complete, and financial risks. Support can include initial budget review, ongoing tracking, variance analysis, scenario forecasting, invoice and change-order assessment, or recovery of a fragmented trial budget.
Global Reach
Therapeutic Area Coverage
Years of Experience
START A CONVERSATION
Select the support you need and share a few details about your project. We’ll use this information to route your inquiry to the appropriate BioBoston team member.
Please do not submit confidential, patient-identifiable, or proprietary information through this form.
The engagement should be scoped around the current state of the work, the intended decision or milestone, the source package, and the sponsor's approval responsibilities.
Compare assumptions, units, volumes, rates, pass-throughs, exclusions, contingencies, milestones, and change mechanisms before approval.
Reconcile baseline, commitments, actuals, invoices, accrual inputs, forecasts, change orders, and cost-to complete against scope and timeline.
Determine whether variances arise from scope, protocol, enrollment, sites, countries, duration, vendors, pass-throughs, changes, errors, or delayed decisions.
when needed
Problems
The service is most valuable when the team can identify the specific control gap, decision, deliverable, or
recovery need rather than requesting generic capacity.
Scope
The exact scope depends on the maturity of the work, the quality of the inputs, the sponsor’s procedures,
the review model, and the target milestone.
Deliverables
Deliverables should be confirmed at kickoff and linked to defined sponsor decisions, review cycles, and downstream handoffs.
Client inputs
The sponsor does not need every detail finalized before kickoff, but approved decisions, open questions, source owners, reviewers, and deadlines must be distinguishable.
Process
1. Confirm the purpose, current state, intended use, milestone, stakeholders, responsibilities, systems or vendors, and agreed deliverables.
2. Review available source materials, prior decisions, procedures, evidence, and open issues; issue a focused gap and dependency list.
3. Develop the work plan, specifications, document, assessment, or control package included in scope.
4. Coordinate review through named sponsor and cross-functional decision owners and maintain a controlled open-item and comment process.
5. Perform the agreed technical, quality, consistency, or operational checks and document remaining risks or limitations.
6. Prepare the approved handoff, implementation, submission, remediation, archive, or next-step package as defined in scope.
Considerations
The work should remain proportionate to the risk and intended use, follow the sponsor’s controlled process, and preserve clear sponsor decision authority.
Engagement options
BioBoston leads the defined scope from assessment and planning through drafting or execution, review, quality control, and handoff.
BioBoston addresses a specific section, decision, backlog, finding, vendor issue, or stalled deliverable without expanding the engagement unnecessarily.
BioBoston provides an objective second-line review, oversight role, or embedded specialist while the sponsor or another vendor retains primary execution.
RELATED SERVICES
Develop early trial concepts, vendor-selection strategy, and initial budget assumptions before detailed operational control begins.
Connect schedule scenarios, delays, acceleration, milestones, and duration changes to forecast and cost to-complete.
Manage vendor deliverables, performance, issues, accountability, and escalation that affect invoices, forecasts, and changes.
Assess and control financial exposure while stabilizing an underperforming or disrupted clinical trial.
Expertise
Budget-management experience should match the study phase, countries and sites, vendor and contract model, protocol complexity, enrollment and timeline risk, pass-through structure, currencies, and sponsor financial controls.
RESOURCES
Explore the following resources for additional insights and information relevant to this service.
A planned template for baseline, commitments, actuals, invoices, accruals, forecast, changes, cost to complete, variance, and risk.
A planned checklist for scope, units, volumes, rates, assumptions, pass-throughs, exclusions, contingencies, milestones, and change terms.
A planned tool for scope trigger, evidence, units, rates, timeline, operational impact, alternatives, negotiation, approval, and forecast.
Use an Excel-ready clinical trial budget template to track baseline, forecast, actuals, accruals, change orders, estimate-at-completion, and variance across CROs and vendors.
FAQs
Support may include proposal and baseline review, integrated tracking, actual and invoice reconciliation, accrual inputs, variance analysis, forecast and cost-to-complete, scenario planning, change-order review, and governance reporting.
Yes. Review can assess scope, assumptions, units, volumes, rates, pass throughs, exclusions,
contingencies, milestones, responsibilities, and change mechanisms. Legal and final procurement
decisions remain with the sponsor.
Yes, when contracts, statements of work, rate and unit schedules, purchase orders, deliverables, approvals, and supporting evidence are available.
A review should connect the trigger to scope, units, rates, timing, prior commitments, contractual terms, operational impact, alternatives, negotiation questions, and the updated forecast.
Yes. Timeline, enrollment, sites, duration, vendors, supply, data, safety, and reporting are major forecast drivers and should be reconciled with budget scenarios.
No. It improves visibility, controls, forecasting, evidence, and decision making, but final cost depends on study scope, performance, changes, vendors, sites, participants, data, safety, supply, and sponsor
decisions.
PROJECT FORM
Share the study, vendors, current budget and forecast, contracts, invoice or change-order concerns, timeline status, and the financial decision you need to make. A BioBoston team member will review the request and follow up regarding fit and possible next steps.
Please do not submit confidential, patient-identifiable, or proprietary information through this form.
A productive first discussion identifies the scope, vendors, contracts, baseline, actuals, forecast, invoices, changes, timeline, and financial decision. BioBoston can then define the review, tracking, scenario, negotiation, or recovery scope.
